Overview
- George McKinty, 30, was confirmed to have relapsing‑remitting multiple sclerosis after an October 2021 MRI showed brain and spinal lesions and a March 2022 lumbar puncture completed the diagnosis.
- He began intravenous ocrelizumab soon after diagnosis and reports no relapses since 2021, with the MS Trust citing around a 70% reduction in relapses for this therapy.
- Persistent damage leaves him with double vision that impairs depth perception and limits sport, alongside mobility issues he addresses through physiotherapy and regular exercise.
- Bladder dysfunction disrupts sleep with nocturia four to five times nightly and requires self‑catheterisation, and he plans to pay privately for Botox after NHS delays.
- He describes a reduced social life and a loss of identity, and the charity Overcoming MS says evidence‑based lifestyle measures can improve quality of life but are too often overlooked.